Mary Vijjeswarapu, MD
Pain Medicine · West Hollywood, CANPI 1962765180
Payments from drug & device makers
Across 154 payments — averaging $142.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$12K
- Medtronic$4K
- Vertex$4K
- Nevro Corp.$973
- Avanos Medical$289
- Vertos Medical, Inc.$194
- plus $469 from 6 others
What the payments were for
- Consulting fees$4,20319%
- Speaking & faculty fees$8,20237%
- Travel & lodging$3,01914%
- Food & beverage$6,56330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 72 | $11,600 |
| Medtronic(2 entities) | 51 | $4,369 |
| Vertex | 5 | $4,092 |
| Nevro Corp. | 13 | $973 |
| Avanos Medical | 3 | $289 |
| Vertos Medical, Inc. | 4 | $194 |
| Nalu Medical, Inc. | 1 | $143 |
| Abbott | 1 | $133 |
| Stimwave Technologies Incorporated | 1 | $53 |
| Stryker | 1 | $52 |
| SPR Therapeutics, Inc | 1 | $52 |
| Flowonix Medical Incorporated | 1 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WAVEWRITER ALPHA$3,959
- JOURNAVX$3,936
- GENERAL - THERAPIES$3,200
- WaveWriter Alpha Prime 16$1,743
- OSTEOCOOL RF ABLATION$1,446
- INTELLIS$1,150
- SUPERION$504
- INTELLIS ADAPTIVESTIM$444
- Senza Spinal Cord Stimulation System$420
- SPECTRA WAVEWRITER$416
- GENERAL PAIN MANAGEMENT$410
- GENERATOR$155
- KYPHON Balloon Kyphoplasty$147
- Nalu Neurostimulation System$143
- ETERNA$133
- Vanta$128
- Omnia$127
- TARGETSTIM$124
- Senza$120
- COOLIEF* COOLED RADIOFREQUENCY$116
How this compares
$21,986 in reported general payments places this provider in the 85th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 28 | $8,574 |
| Duloxetine Hcl | 16 | $573 |
| Gabapentin | 23 | $462 |
| Methocarbamol | 12 | $224 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $191 |
| Carisoprodol | 25 | $134 |
| Cyclobenzaprine Hcl | 12 | $64 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in West Hollywood
- Howard RosnerWest Hollywood$79K
- Eric GrigsbyNapa$3.2M
- Jason PopeSanta Rosa$2.8M
- Javid GhandehariSanta Monica$2.7M
- Alexander HerselThousand Oaks$2.1M
- Krishnan ChakravarthyTemecula$1.9M
- Kasra AmirdelfanWalnut Creek$1.7M
- Ramana NaiduLarkspur$1.6M
- Foead GeulaStudio City$1.3M
- Xiang QianRedwood City$941K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.